Peer review reports
From: Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis
Original Submission | ||
---|---|---|
24 Jul 2019 | Submitted | Original manuscript |
30 Jul 2019 | Author responded | Author comments - Luca Richeldi |
Resubmission - Version 2 | ||
30 Jul 2019 | Submitted | Manuscript version 2 |
15 Aug 2019 | Reviewed | Reviewer Report - Gary M. Hunninghake |
20 Aug 2019 | Reviewed | Reviewer Report - Paolo Spagnolo |
21 Nov 2019 | Author responded | Author comments - Luca Richeldi |
Resubmission - Version 3 | ||
21 Nov 2019 | Submitted | Manuscript version 3 |
22 Nov 2019 | Reviewed | Reviewer Report - Paolo Spagnolo |
8 Dec 2019 | Reviewed | Reviewer Report - Paola Faverio |
11 Dec 2019 | Author responded | Author comments - Luca Richeldi |
Resubmission - Version 4 | ||
11 Dec 2019 | Submitted | Manuscript version 4 |
Publishing | ||
12 Dec 2019 | Editorially accepted | |
8 Jan 2020 | Article published | 10.1186/s12890-019-1030-4 |